Trial Profile
Clinical efficacy of epinastine hydrochloride ophthalmic solution for allergic conjunctivitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2017
Price :
$35
*
At a glance
- Drugs Epinastine (Primary)
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- 18 Aug 2017 Status changed from recruiting to completed.
- 27 Jul 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 06 Feb 2015 New trial record